These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9121892)

  • 1. Fibrin sheaths in vascular access devices.
    Gabriel J
    Nurs Times; 1997 Mar 5-11; 93(10):56-7. PubMed ID: 9121892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy extravasation: a consequence of fibrin sheath formation around venous access devices.
    Mayo DJ; Pearson DC
    Oncol Nurs Forum; 1995 May; 22(4):675-80. PubMed ID: 7675669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin sheath formation and chemotherapy extravasation: a case report.
    Mayo DJ
    Support Care Cancer; 1998 Jan; 6(1):51-6. PubMed ID: 9458537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nurse's guide to understanding and treating thrombotic occlusion of central venous access devices.
    McKnight S
    Medsurg Nurs; 2004 Dec; 13(6):377-82. PubMed ID: 15714740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism and management of persistent withdrawal occlusion.
    Tschirhart JM; Rao MK
    Am Surg; 1988 Jun; 54(6):326-8. PubMed ID: 3377325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator for central venous access device occlusion.
    Hooke C
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):174-8. PubMed ID: 10944865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a protocol to prevent and treat pediatric central venous catheter occlusions.
    Harris JL; Maguire D
    J Intraven Nurs; 1999; 22(4):194-8. PubMed ID: 10476135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central venous catheter occlusion.
    Richardson D
    Oncol Nurs Forum; 1999 May; 26(4):683. PubMed ID: 10337640
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of central venous catheter occlusions and repairs.
    Reed T; Phillips S
    J Intraven Nurs; 1996; 19(6):289-94. PubMed ID: 9060354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central venous catheter occlusion: successful management strategies.
    Andris DA; Krzywda EA
    Medsurg Nurs; 1999 Aug; 8(4):229-36; quiz 237-8. PubMed ID: 10661159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of central venous access device occlusion. Implications for nursing practice.
    Bagnall-Reeb H
    J Intraven Nurs; 1998; 21(5 Suppl):S115-21. PubMed ID: 9814286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous access devices.
    McKay L
    Nurs Stand; 2006 Jun 21-27; 20(41):67. PubMed ID: 16827206
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing occlusion in central venous catheters.
    Simcock L
    Nurs Times; 2001 May 24-30; 97(21):36-8. PubMed ID: 11954381
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
    Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [IChoosing the best disposable vascular access device].
    Besombes P
    Perspect Infirm; 2006; 3(6):28-32. PubMed ID: 16909727
    [No Abstract]   [Full Text] [Related]  

  • 16. Make the right choice of vascular access device.
    Cowley K
    Prof Nurse; 2004 Jun; 19(10):43-6. PubMed ID: 15233073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin sheaths and central venous catheter occlusions: diagnosis and management.
    Santilli J
    Tech Vasc Interv Radiol; 2002 Jun; 5(2):89-94. PubMed ID: 12489047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multidisciplinary approach to vascular access in children.
    Schultz TR; Durning S; Niewinski M; Frey AM
    J Spec Pediatr Nurs; 2006 Oct; 11(4):254-6. PubMed ID: 16999748
    [No Abstract]   [Full Text] [Related]  

  • 19. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
    Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting therapy with central venous access devices.
    Hadaway LC
    Nursing; 2008 Jun; 38(6):34-40; quiz 40-1. PubMed ID: 18497658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.